Predominance of high-grade pathway in breast cancer development of Middle East women-Reference-Cited by-同舟云学术

Predominance of high-grade pathway in breast cancer development of Middle East women

Published:2005-04-01 Issue:7 Volume:18 Page:891-897
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Al-Kuraya Khawla,Schraml Peter,Sheikh Salwa,Amr Samir,Torhorst Joachim,Tapia Coya,Novotny Hedvika,Spichtin Hanspeter,Maurer Robert,Mirlacher Martina,Simon Ronald,Sauter Guido

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800408.pdf

Reference22 articles.

1. van't Veer LJ, Dai H, van de Vijver MJ, et al. Expression profiling predicts outcome in breast cancer. Breast Cancer Res 2003;5:57–58.

2. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999–2009.

3. Huang E, Cheng SH, Dressman H, et al. Gene expression predictors of breast cancer outcomes. Lancet 2003;361:1590–1596.

4. Hartmann A, Blaszyk H, Saitoh S, et al. High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population. Br J Cancer 1996;73:896–901.

5. Hartmann A, Rosanelli G, Blaszyk H, et al. Novel pattern of P53 mutation in breast cancers from Austrian women. J Clin Invest 1995;95:686–689.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression;Cell Death Discovery;2024-07-23

2. Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity;Scientific Reports;2023-11-27

3. Identification and Characterization of Atm Founder Germline Mutation in Brca-negative Breast Cancer Patients of Arab Ethnicity;2023-07-31

4. A comparison of invasive lobular carcinoma with other invasive breast cancers at Tygerberg Academic Hospital;South African Journal of Surgery;2022-09

5. Evaluation PD-L1, CD8 and CD20 as early predictor and tracking markers for breast cancer (BC) in Egypt;Heliyon;2022-05